Altered purinergic signaling in CD73-deficient mice inhibits tumor progression

European Journal of Immunology

Volumn 41, Issue 5, 2011, Pages 1231-1241

  Yegutkin, Gennady G ^a   Marttila Ichihara, Fumiko ^a   Karikoski, Marika ^a   Niemelä, Jussi ^a   Laurila, Juha P ^a   Elima, Kati ^a,b   Jalkanen, Sirpa ^a   Salmi, Marko ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

ATP; Ecto 5' nucleotidase CD73; Tumor infiltrating leukocytes; Type 2 macrophages

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE TRIPHOSPHATASE; ALPHA,BETA METHYLENE ADENOSINE 5' DIPHOSPHATE; APYRASE; GAMMA INTERFERON; MANNOSE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; NUCLEOTIDE; PURINERGIC RECEPTOR; PYROPHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; LEUKOCYTE; MACROPHAGE; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TUMOR GROWTH; TUMOR IMMUNITY;

5'-NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASES; ANIMALS; APYRASE; CELL PROLIFERATION; DISEASE PROGRESSION; INTERFERON-GAMMA; LECTINS, C-TYPE; LYMPHOCYTES; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MANNOSE-BINDING LECTINS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM METASTASIS; NITRIC OXIDE SYNTHASE TYPE II; PURINES; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 79955153842     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041292     Document Type: Article

References (56)

1. Burnstock, G., Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 2007. 87: 659-797.
2. Yegutkin, G. G., Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 2008. 1783: 673-694.
3. Stagg, J. and Smyth, M. J., Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010. 29: 5346-5358.
4. Sitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A. and Thiel, M., Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 2004. 22: 657-682.
5. Resta, R., Yamashita, Y. and Thompson, L. F., Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol. Rev. 1998. 161: 95-109.
6. Airas, L., Salmi, M. and Jalkanen, S., Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium. J. Immunol. 1993. 151: 4228-4238.
7. Colgan, S. P., Eltzschig, H. K., Eckle, T. and Thompson, L. F., Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal. 2006. 2: 351-360.
8. Ring, S., Enk, A. H. and Mahnke, K., ATP activates regulatory T Cells in vivo during contact hypersensitivity reactions. J. Immunol. 2010. 184: 3408-3416.
9. Kobie, J. J., Shah, P. R., Yang, L., Rebhahn, J. A., Fowell, D. J. and Mosmann, T. R., T regulatory and primed uncommitted CD4T cells express CD73, which suppresses effector CD4T cells by converting 5'-adenosine monophosphate to adenosine. J. Immunol. 2006. 177: 6780-6786.
10. Mandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., Lang, S. et al., Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+regulatory T cells. J. Biol. Chem. 2010. 285: 7176-7186.
11. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F. et al., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 2007. 204: 1257-1265.
12. Airas, L., Hellman, J., Salmi, M., Bono, P., Puurunen, T., Smith, D. J. and Jalkanen, S., CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J. Exp. Med. 1995. 182: 1603-1608.
13. Thompson, L. F., Eltzschig, H. K., Ibla, J. C., Van De Wiele, C. J., Resta, R., Morote-Garcia, J. C. and Colgan, S. P., Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 2004. 200: 1395-1405.
14. Takedachi, M., Qu, D., Ebisuno, Y., Oohara, H., Joachims, M. L., McGee, S. T., Maeda, E. et al., CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes. J. Immunol. 2008. 180: 6288-6296.
15. Reutershan, J., Vollmer, I., Stark, S., Wagner, R., Ngamsri, K. C. and Eltzschig, H. K., Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J. 2009. 23: 473-482.
16. Hart, M. L., Much, C., Gorzolla, I. C., Schittenhelm, J., Kloor, D., Stahl, G. L. and Eltzschig, H. K., Extracellular adenosine production by ecto-5'-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology 2008. 135: 1739-1750 e1733.
17. Eckle, T., Krahn, T., Grenz, A., Kohler, D., Mittelbronn, M., Ledent, C., Jacobson, M. A. et al., Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation 2007. 115: 1581-1590.
18. Kiss, J., Yegutkin, G. G., Koskinen, K., Savunen, T., Jalkanen, S. and Salmi, M., IFN-beta protects from vascular leakage via up-regulation of CD73. Eur. J. Immunol. 2007. 37: 3334-3338.
19. Mills, J. H., Thompson, L. F., Mueller, C., Waickman, A. T., Jalkanen, S., Niemela, J., Airas, L. and Bynoe, M. S., CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2008. 105: 9325-9330.
20. Spychala, J., Tumor-promoting functions of adenosine. Pharmacol. Ther. 2000. 87: 161-173.
21. Wang, L., Zhou, X., Zhou, T., Ma, D., Chen, S., Zhi, X., Yin, L. et al., Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J. Cancer Res. Clin. Oncol. 2008. 134: 365-372.
22. Mosser, D. M. and Edwards, J. P., Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008. 8: 958-969.
23. Gordon, S. and Martinez, F. O., Alternative activation of macrophages: mechanism and functions. Immunity 2010. 32: 593-604.
24. Biswas, S. K. and Mantovani, A., Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010. 11: 889-896.
25. Yamashita, Y., Hooker, S. W., Jiang, H., Laurent, A. B., Resta, R., Khare, K., Coe, A. et al., CD73 expression and fyn-dependent signaling on murine lymphocytes. Eur. J. Immunol. 1998. 28: 2981-2990.
26. Yang, L., Kobie, J. J. and Mosmann, T. R., CD73 and Ly-6A/E distinguish in vivo primed but uncommitted mouse CD4 T cells from type 1 or type 2 effector cells. J. Immunol. 2005. 175: 6458-6464.
27. Montesinos, M. C., Shaw, J. P., Yee, H., Shamamian, P. and Cronstein, B. N., Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am. J. Pathol. 2004. 164: 1887-1892.
28. Nair, M. G., Du, Y., Perrigoue, J. G., Zaph, C., Taylor, J. J., Goldschmidt, M., Swain, G. P. et al., Alternatively activated macrophage-derived RELM-alpha is a negative regulator of type 2 inflammation in the lung. J. Exp. Med. 2009. 206: 937-952.
29. Asano, K., Nabeyama, A., Miyake, Y., Qiu, C. H., Kurita, A., Tomura, M., Kanagawa, O. et al., CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 2011. 34: 85-95.
30. Qian, B. Z. and Pollard, J. W., Macrophage diversity enhances tumor progression and metastasis. Cell 2010. 141: 39-51.
31. Nishikawa, H. and Sakaguchi, S., Regulatory T cells in tumor immunity. Int. J. Cancer 2010. 127: 759-767.
32. Mantovani, A., The growing diversity and spectrum of action of myeloid-derived suppressor cells. Eur. J. Immunol. 2010. 40: 3317-3320.
33. Sica, A., Porta, C., Riboldi, E. and Locati, M., Convergent pathways of macrophage polarization: The role of B cells. Eur. J. Immunol. 2010. 40: 2131-2133.
34. Martinez, F. O., Gordon, S., Locati, M. and Mantovani, A., Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 2006. 177: 7303-7311.
35. Nalos, M., Huang, S., Sluyter, R., Khan, A., Santner-Nanan, B., Nanan, R. and McLean, A. S., "Host tissue damage" signal ATP impairs IL-12 and IFNgamma secretion in LPS stimulated whole human blood. Intensive Care Med. 2008. 34: 1891-1897.
36. Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J. and Schreiber, R. D., IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001. 410: 1107-1111.
37. Ohtsuka, T., Changelian, P. S., Bouis, D., Noon, K., Harada, H., Lama, V. N. and Pinsky, D. J., Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation. J. Immunol. 2010. 185: 1321-1329.
38. Alam, M. S., Kurtz, C. C., Rowlett, R. M., Reuter, B. K., Wiznerowicz, E., Das, S., Linden, J. et al., CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J. Infect. Dis. 2009. 199: 494-504.
39. Barnholt, K. E., Kota, R. S., Aung, H. H. and Rutledge, J. C., Adenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 727 to reduce macrophage activation. J. Immunol. 2009. 183: 6767-6777.
40. Pelegrin, P. and Surprenant, A., Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J. 2009. 28: 2114-2127.
41. Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V. and Di Virgilio, F., Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 2008. 3: e2599.
42. Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K. et al., Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 2009. 15: 1170-1178.
43. Weigert, A. and Brune, B., Nitric oxide, apoptosis and macrophage polarization during tumor progression. Nitric Oxide 2008. 19: 95-102.
44. Ekmekcioglu, S., Ellerhorst, J., Smid, C. M., Prieto, V. G., Munsell, M., Buzaid, A. C. and Grimm, E. A., Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin. Cancer Res. 2000. 6: 4768-4775.
45. Jackson, S. W., Hoshi, T., Wu, Y., Sun, X., Enjyoji, K., Cszimadia, E., Sundberg, C. and Robson, S. C., Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice. Am. J. Pathol. 2007. 171: 1395-1404.
46. Sun, X., Wu, Y., Gao, W., Enjyoji, K., Csizmadia, E., Muller, C. E., Murakami, T. and Robson, S. C., CD39/ENTPD1 expression by CD4+Foxp3+regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 2010. 139: 1030-1040.
47. Wu, Y., Sun, X., Kaczmarek, E., Dwyer, K. M., Bianchi, E., Usheva, A. and Robson, S. C., RanBPM associates with CD39 and modulates ecto-nucleotidase activity. Biochem. J. 2006. 396: 23-30.
48. Chen, Y., Corriden, R., Inoue, Y., Yip, L., Hashiguchi, N., Zinkernagel, A., Nizet, V. et al., ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 2006. 314: 1792-1795.
49. Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K. M. and Smyth, M. J., Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 2010. 107: 1547-1552.
50. Jin, D., Fan, J., Wang, L., Thompson, L. F., Liu, A., Daniel, B. J., Shin, T. et al., CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res. 2010. 70: 2245-2255.
51. Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N., Karhausen, J., Eltzschig, H. K., Hansen, K. R. et al., Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 2002. 110: 993-1002.
52. Marttila-Ichihara, F., Turja, R., Miiluniemi, M., Karikoski, M., Maksimow, M., Niemela, J., Martinez-Pomares, L. et al., Macrophage mannose receptor on lymphatics controls cell trafficking. Blood 2008. 112: 64-72.
53. Marttila-Ichihara, F., Auvinen, K., Elima, K., Jalkanen, S. and Salmi, M., Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+myeloid cells into tumors. Cancer Res. 2009. 69: 7875-7883.
54. Yegutkin, G. G., Hytonen, J., Samburski, S. S., Yrjanainen, H., Jalkanen, S. and Viljanen, M. K., Disordered lymphoid purine metabolism contributes to the pathogenesis of persistent Borrelia garinii infection in mice. J. Immunol. 2010. 184: 5112-5120.
55. Marttila-Ichihara, F., Castermans, K., Auvinen, K., Oude Egbrink, M. G., Jalkanen, S., Griffioen, A. W. and Salmi, M., Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice. J. Immunol. 2010. 184: 3164-3173.
56. Zimmermann, H., 5'-nucleotidase: molecular structure and functional aspects. Biochem. J. 1992. 285: 345-365.